Sign in

CIK 0001175151

  • Non-accelerated filer
  • Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980373793
Phone
+1 973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Open-market sale 10% owner sold 124,281 shares at an average $3.44 ($427,662)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Chief Financial Officer bought 2,125 shares at $7.05 ($14,981)
  4. 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.50 ($30,000)
  5. 4 Option exercise President and CEO acquired 3,467 shares (option exercise)
  6. 4 Open-market sale Director sold 6,774 shares at $6.22 ($42,122)
  7. 4 Open-market sale Director sold 10,000 shares at $6.39 ($63,913)
  8. 4 Open-market sale Director sold 10,000 shares at $6.26 ($62,591)
  9. 4 Open-market sale Director sold 10,000 shares at $6.44 ($64,361)
  10. 4 Open-market sale Director sold 10,000 shares at $6.64 ($66,373)
  11. 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,600)
  12. 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,585)
  13. 4 Open-market sale Director sold 10,000 shares at $6.39 ($63,937)
  14. 4 Open-market sale Director sold 10,000 shares at $7.26 ($72,631)
  15. 4 Open-market sale Director sold 10,000 shares at $6.26 ($62,593)
  16. 4 Open-market sale Director sold 10,000 shares at $6.48 ($64,827)
  17. 4 Open-market sale Director sold 10,000 shares at $6.34 ($63,397)
  18. 4 Open-market sale Director sold 10,000 shares at $6.28 ($62,777)
  19. 4 Open-market sale Director sold 10,000 shares at $6.33 ($63,303)
  20. 4 Derivatives Options or other derivatives

Page 12 of 20 · 395 filings